What is the standard adult mFOLFOX6 (modified FOLFOX6) chemotherapy regimen and dosing schedule?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

mFOLFOX6 Standard Dosing Regimen

The standard mFOLFOX6 regimen consists of oxaliplatin 85 mg/m² IV over 2 hours on day 1, leucovorin 400 mg/m² IV over 2 hours on day 1,5-FU 400 mg/m² IV bolus on day 1, followed by 5-FU 2400 mg/m² (1200 mg/m²/day × 2 days) as continuous infusion over 46-48 hours, repeated every 2 weeks. 1, 2

Detailed Dosing Components

Day 1 Administration:

  • Oxaliplatin: 85 mg/m² IV infusion over 2 hours
  • Leucovorin: 400 mg/m² IV infusion over 2 hours (can be given concurrently with oxaliplatin using Y-connector)
    • Alternative: Levoleucovorin 200 mg/m² (equivalent dose) 1
  • 5-FU bolus: 400 mg/m² IV push immediately after leucovorin
  • 5-FU continuous infusion: 2400 mg/m² over 46-48 hours (1200 mg/m²/day for 2 days)

Cycle Frequency:

  • Repeat every 14 days (2 weeks) 1, 2

Critical Safety Considerations

Order chemotherapy in 24-hour units (1200 mg/m²/day) rather than total dose (2400 mg/m² over 46 hours) to minimize medication errors. This is an explicit NCCN recommendation to prevent potentially fatal dosing mistakes. 1

Clinical Context & Applications

This regimen is used across multiple settings:

  • Adjuvant therapy for stage III colon cancer (typically 12 cycles = 6 months) 1
  • First-line metastatic disease (alone or with biologics like bevacizumab 5 mg/kg day 1, or panitumumab 6 mg/kg day 1 in RAS wild-type tumors) 2
  • High-risk stage II colon cancer 1

Duration Considerations

For adjuvant treatment, recent evidence from the IDEA collaboration suggests that 3 months (6 cycles) may be sufficient for low-risk stage III patients (T1-3, N1), while 6 months (12 cycles) remains standard for high-risk patients (T4 or N2), balancing efficacy against cumulative oxaliplatin neurotoxicity 3. However, this represents a nuanced decision based on individual risk stratification.

Common Pitfalls to Avoid

  • Never use bolus 5-FU regimens with oxaliplatin—infusional 5-FU is mandatory for safety and efficacy 1
  • Do not confuse with FOLFOX4, which uses different leucovorin dosing (200 mg/m² over 2 hours on days 1 and 2) and different 5-FU administration (400 mg/m² bolus then 600 mg/m² over 22 hours on days 1 and 2) 1
  • Ensure adequate hydration and antiemetic prophylaxis
  • Monitor for cumulative peripheral neuropathy from oxaliplatin—consider dose reduction or discontinuation if grade 2-3 neuropathy develops

References

Guideline

nccn clinical practice guidelines in oncology: colon cancer.

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

Guideline

colon cancer.

Journal of the National Comprehensive Cancer Network : JNCCN, 2011

Related Questions

What is the recommended modified FOLFOX6 (mFOLFOX) chemotherapy regimen, including dosing, schedule, and monitoring recommendations?
Can the FOLFOX (oxaliplatin, leucovorin, 5‑fluorouracil) chemotherapy regimen cause hiccups and how should they be managed?
What chemotherapy regimens (peri‑operative FLOT [docetaxel, oxaliplatin, leucovorin, 5‑fluorouracil]; first‑line CAPOX [capecitabine plus oxaliplatin] or FOLFOX [oxaliplatin, leucovorin, 5‑fluorouracil]; HER2 [human epidermal growth factor receptor 2]‑positive with trastuzumab) are recommended for gastric adenocarcinoma, including second‑line options?
What is the management of colonic adenocarcinoma with a pathological classification of pT3N0 (pathological T3, Node 0)?
What is the difference between appendiceal cancer and colorectal (colon) cancer?
What are occlusive conditions and should they be avoided when treating bilateral axillary dermatitis with mometasone furoate (0.1%)?
Should I stop the seated cervical retraction (chin tuck) that provokes mild stinging pain and numbness radiating down my left arm and continue the other gentle home exercises?
How should anifrolumab (Saphnelo) be dosed and administered in an adult with systemic lupus erythematosus refractory to standard therapy?
What empiric antibiotics should be initiated for a patient presenting with both hematochezia and hematemesis?
What are the recommended monitoring guidelines for managing erectile dysfunction?
What are the complications of thoracic outlet syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.